These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10708933)

  • 21. The effects of combined treatment with beta 1-selective receptor antagonists and lipid-lowering drugs on fat metabolism and measures of fatigue during moderate intensity exercise: a placebo-controlled study in healthy subjects.
    Eagles CJ; Kendall MJ
    Br J Clin Pharmacol; 1997 Mar; 43(3):291-300. PubMed ID: 9088584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of increased plasma non-esterified fatty acid concentrations on endurance performance during beta-adrenoceptor blockade.
    van Baak MA; Mooij JM; Wijnen JA
    Int J Sports Med; 1993 Jan; 14(1):2-8. PubMed ID: 8440540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. beta-1 and beta-2, but not alpha-1 and alpha-2, adrenoceptor blockade delays rat cutaneous wound healing.
    Romana-Souza B; Santos JS; Monte-Alto-Costa A
    Wound Repair Regen; 2009; 17(2):230-9. PubMed ID: 19320892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resting sympathetic activity is associated with the sympathetically mediated component of energy expenditure following a meal.
    Limberg JK; Malterer KR; Matzek LJ; Levine JA; Charkoudian N; Miles JM; Joyner MJ; Curry TB
    Physiol Rep; 2017 Aug; 5(16):. PubMed ID: 28867675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of beta-adrenoceptor blockade on thermoregulation during prolonged exercise.
    Gordon NF; Krüger PE; Van Rensburg JP; Van der Linde A; Kielblock AJ; Cilliers JF
    J Appl Physiol (1985); 1985 Mar; 58(3):899-906. PubMed ID: 2858466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-adrenoceptor antagonism and the hyperthyroid rat heart.
    Amos G; Kerr D; Sernia C; Brown L
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):336-43. PubMed ID: 7526070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute effect of propranolol on resting energy expenditure in hyperthyroid patients.
    Senn JR; Löliger RC; Fischer JGW; Bur F; Maushart CI; Betz MJ
    Front Endocrinol (Lausanne); 2022; 13():1026998. PubMed ID: 36743920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of beta-adrenergic receptor stimulation and blockade on substrate metabolism during submaximal exercise.
    Mora-Rodriguez R; Hodgkinson BJ; Byerley LO; Coyle EF
    Am J Physiol Endocrinol Metab; 2001 May; 280(5):E752-60. PubMed ID: 11287358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a novel beta-adrenoceptor agonist (Ro 40-2148) on resting energy expenditure in obese women.
    Haesler E; Golay A; Güzelhan C; Schutz Y; Hartmann D; Jéquier E; Felber JP
    Int J Obes Relat Metab Disord; 1994 May; 18(5):313-22. PubMed ID: 7914795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of selective and nonselective beta-adrenoceptor blockade on thermoregulation during prolonged exercise in heat.
    Gordon NF
    Am J Cardiol; 1985 Apr; 55(10):74D-78D. PubMed ID: 3993552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy.
    Wellstein A; Palm D; Belz GG; Butzer R; Polsak R; Pett B
    Eur Heart J; 1987 Dec; 8 Suppl M():3-8. PubMed ID: 2897299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
    Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
    Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. β
    Cook RF; Bussey CT; Mellor KM; Cragg PA; Lamberts RR
    Exp Physiol; 2017 Aug; 102(8):911-923. PubMed ID: 28543947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of various beta-receptor blockers on metabolic and circulatory parameters during physical exertion].
    Koebe P; Rost R; Reinke A; Nagel N; Merten U
    Arzneimittelforschung; 1985; 35(2):522-9. PubMed ID: 2859861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated energy expenditure in cancer patients with solid tumours.
    Hyltander A; Drott C; Körner U; Sandström R; Lundholm K
    Eur J Cancer; 1991; 27(1):9-15. PubMed ID: 1826450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-adrenoceptor blockade by atenolol, metoprolol and propranolol in the anaesthetized cat.
    Lundgren B; Carlsson E; Herrmann I
    Eur J Pharmacol; 1979 May; 55(3):263-8. PubMed ID: 37096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thermic effect and substrate oxidation in response to intravenous nutrition in cancer patients who lose weight.
    Lindmark L; Bennegård K; Edén E; Svaninger G; Ternell M; Lundholm K
    Ann Surg; 1986 Dec; 204(6):628-36. PubMed ID: 3098197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular and metabolic response to adrenaline infusion in weight-losing patients with and without cancer.
    Drott C; Persson H; Lundholm K
    Clin Physiol; 1989 Oct; 9(5):427-39. PubMed ID: 2582730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole body lipid and energy metabolism in the cancer patient.
    Legaspi A; Jeevanandam M; Starnes HF; Brennan MF
    Metabolism; 1987 Oct; 36(10):958-63. PubMed ID: 3657515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta 1-selective and non-selective beta-adrenoceptor blockade, anaerobic threshold and respiratory gas exchange during exercise.
    McLeod AA; Knopes KD; Shand DG; Williams RS
    Br J Clin Pharmacol; 1985 Jan; 19(1):13-20. PubMed ID: 2858214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.